- SG$43.08m
- SG$9.27m
- SG$71.54m
Annual income statement for Ellipsiz, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 55.6 | 59.1 | 55.1 | 57.8 | 71.5 |
| Cost of Revenue | |||||
| Gross Profit | 12.1 | 11.7 | 11.6 | 12.2 | 12.8 |
| Selling / General / Administrative Expenses | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 52 | 59.2 | 61.7 | 57.3 | 70.1 |
| Operating Profit | 3.59 | -0.053 | -6.62 | 0.416 | 1.48 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 3.8 | 1.11 | -5.06 | 1.73 | 2.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.19 | 0.698 | -5.48 | 1.05 | 1.68 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 2.75 | 2.05 | -3.84 | 3.63 | 1.93 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.75 | 2.05 | -3.84 | 3.63 | 1.93 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.016 | 0.012 | 0.003 | 0.012 | 0.01 |
| Dividends per Share | |||||
| Special Dividends per Share |